Children’s Hospital Boston to test Titan’s surgical robot
TORONTO – Titan Medical Inc. announced that it has signed a non-binding memorandum of understanding (MOU) with Children’s Hospital Boston. Under the terms of the agreement, Children’s Hospital Boston will test and evaluate the company’s Amadeus Composer, a surgical robotic system. Children’s Hospital Boston will provide the Company with detailed feedback as appropriate.
Dr. Reiza Rayman (pictured), President of Titan Medical Inc., commented, “We are extremely pleased to work with Children’s Hospital Boston, a recognized leader in pediatric care in the U.S. This effort will validate and expand the use of our Next Generation Surgical Robotic Platform into clinical trials.”
Dr. Nguyen, the Director of the Robotic Surgery, Research and Training Center, commented, “Children’s Hospital Boston strives to be the leader in providing the safest and most effective care for children. Robotic technology is integral to our ability to offer innovations that improve pediatric surgical care at our institution. We are very excited to be able to participate in the evaluation of the Titan Next Generation Surgical Robotic Platform.”
About Children’s Hospital Boston
Founded in 1869 as a 20-bed hospital for children, Children’s Hospital Boston has been ranked as one of the nation’s best pediatric hospitals by U.S. News & World Report for the past 21 years. Children’s is the primary pediatric teaching hospital of Harvard Medical School and the largest provider of health care to Massachusetts children. In addition to 395 pediatric and adolescent inpatient beds and 228 outpatient programs, Children’s houses the world’s largest research enterprise based at a pediatric medical center, where its discoveries benefit both children and adults. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Children’s research community. For more information about the hospital visit: www.childrenshospital.org/newsroom.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian company focused on the development and commercialization of robotic surgical technologies. The company is currently developing Amadeus Composer, a surgical system that has a uniquely designed external robot and flexible instruments, and allows surgeons to overcome constraints of surgical procedures in small to medium spaces. Amadeus Maestro, the Company’s next generation 4-armed robotic surgical system with advanced communication and training, utilizes the Titan True Touch Technology and is targeted to surgical procedures in large spaces. Robotic surgery has developed over the past 10 years into a proven and growing method of treatment. The global robotic surgical market size is currently estimated to be approximately $1 billion and is estimated to grow to $5 billion by 2015 with potential for placement of 6,000 robotic surgical systems. The Company is researching and developing innovative technologies to empower surgeons to use robots in the operating room of the future. For more information, visit the Company’s website at www.titanmedicalinc.com.
Posted November 17, 2011